Join Precision CRISPR Gene Editing Community in Europe
Be part of a dedicated community in Europe, striving to realise the drug discovery & gene therapy applications of optimised CRISPR systems.
With on-going investments in precision CRISPR-Cas and the open accessibility of this technology, it is critical to know how to translate the ability to make precise genetic edits in living cells and deliver CRISPR-based ex vivo & in vivo therapies to the patient.
- Meet Novartis’ Danilo Madallo and learn about Future perspectives and applications of In Vivo CRISPR Models in the Drug Discovery Process.
- With Cornlab recent move to Switzerland, meet its Principal Investigator Jacob Corn and learn about Gene Repair in Human Hematopoietic Stem Cells.
- Discover how to detect in vitro & ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett, University of Copenhagen
- Find out how Barry Rosen, VP, AstraZeneca is utilising precise genome engineering to empower drug discovery
Sounds interesting? Don’t forget to get your copy of the Event Program and see full speaker list, their agenda sessions and two interactive workshops that will be taking place in London this October.
We look forward to welcoming you in London this October.
Precision CRISPR Team